Cerity Partners LLC Increases Stake in Stryker Corporation (NYSE:SYK)

Cerity Partners LLC boosted its holdings in shares of Stryker Corporation (NYSE:SYK - Free Report) by 17.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 271,069 shares of the medical technology company's stock after buying an additional 40,140 shares during the quarter. Cerity Partners LLC owned approximately 0.07% of Stryker worth $100,912,000 as of its most recent SEC filing.

Other large investors have also recently made changes to their positions in the company. Hunter Associates Investment Management LLC grew its position in Stryker by 2.6% during the 1st quarter. Hunter Associates Investment Management LLC now owns 7,996 shares of the medical technology company's stock worth $2,977,000 after purchasing an additional 200 shares during the last quarter. Financial Gravity Asset Management Inc. purchased a new stake in shares of Stryker during the 1st quarter worth about $2,991,000. Allworth Financial LP boosted its position in Stryker by 0.9% during the first quarter. Allworth Financial LP now owns 84,369 shares of the medical technology company's stock worth $30,461,000 after purchasing an additional 744 shares in the last quarter. Capital Insight Partners LLC raised its stake in shares of Stryker by 8.0% during the 1st quarter. Capital Insight Partners LLC now owns 2,247 shares of the medical technology company's stock worth $836,000 after buying an additional 166 shares during the period. Finally, Stonebrook Private Inc. raised its position in Stryker by 15.0% during the first quarter. Stonebrook Private Inc. now owns 1,767 shares of the medical technology company's stock worth $658,000 after acquiring an additional 230 shares during the period. 77.09% of the stock is owned by institutional investors.

Insiders Place Their Bets

In other Stryker news, Director Ronda E. Stryker sold 200,000 shares of the business's stock in a transaction dated Tuesday, May 6th. The stock was sold at an average price of $376.96, for a total transaction of $75,392,000.00. Following the completion of the sale, the director directly owned 3,417,326 shares of the company's stock, valued at approximately $1,288,195,208.96. The trade was a 5.53% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. 5.90% of the stock is owned by company insiders.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on SYK shares. Truist Financial increased their target price on shares of Stryker from $390.00 to $400.00 and gave the company a "hold" rating in a research report on Monday, May 5th. Evercore ISI increased their price objective on Stryker from $390.00 to $415.00 and gave the stock an "outperform" rating in a research report on Tuesday. Wall Street Zen cut shares of Stryker from a "buy" rating to a "hold" rating in a research report on Friday, June 27th. Sanford C. Bernstein set a $450.00 price target on Stryker in a research report on Monday, May 5th. Finally, BTIG Research set a $403.00 price objective on shares of Stryker and gave the company a "buy" rating in a research note on Monday, April 14th. Five investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the stock. According to MarketBeat, Stryker currently has an average rating of "Moderate Buy" and a consensus target price of $428.55.

Stryker Stock Up 0.7%

SYK opened at $394.67 on Friday. The business has a 50 day moving average price of $384.57 and a 200 day moving average price of $376.97. The company has a debt-to-equity ratio of 0.69, a quick ratio of 1.00 and a current ratio of 1.64. Stryker Corporation has a twelve month low of $314.93 and a twelve month high of $406.19. The firm has a market cap of $150.64 billion, a P/E ratio of 53.33, a price-to-earnings-growth ratio of 2.96 and a beta of 0.91.

Stryker (NYSE:SYK - Get Free Report) last announced its earnings results on Thursday, May 1st. The medical technology company reported $2.84 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.73 by $0.11. The business had revenue of $5.87 billion for the quarter, compared to analyst estimates of $5.68 billion. Stryker had a net margin of 12.31% and a return on equity of 23.74%. Stryker's revenue was up 11.9% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $2.50 earnings per share. Research analysts forecast that Stryker Corporation will post 13.47 EPS for the current year.

Stryker Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, July 31st. Shareholders of record on Monday, June 30th will be given a $0.84 dividend. This represents a $3.36 annualized dividend and a yield of 0.85%. The ex-dividend date is Monday, June 30th. Stryker's payout ratio is presently 45.41%.

Stryker Company Profile

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.